Skip to main content Scroll Top
ITB HOLDINGS LLC | 390 North Orange Avenue, Suite 2300 | Orlando, FL 32801 | United States
IOR

Shipping products to Amazon FBA in 2027? Understand the new CBP foreign importer rules, customs broker requirements, and FDA compliance obligations.

 

US_FDA_Consultant_68
U.S. Customs Compliance | 2027 Regulatory Update

 

New CBP Foreign Importer of Record Rules for 2027: What Foreign Companies, U.S. LLCs and Amazon Sellers Must Know

 

On November 6, 2026, U.S. Customs and Border Protection (CBP) published a major Interim Final Rule titled Heightened Requirements for Foreign Importers of Record (91 FR 69977), implementing Executive Order 14411, "Strengthening Customs Enforcement."

The rule introduces important changes affecting foreign manufacturers, international exporters, foreign-owned U.S. limited liability companies, customs brokers, e-commerce businesses, and companies shipping products to American distribution centers.

Beginning January 5, 2027, importers must evaluate whether they qualify as U.S. importers of record or foreign importers of record under the new regulatory definitions. Foreign importers that do not qualify for the U.S. classification face additional customs entry restrictions.

 

Official Publication

November 6, 2026


Federal Register citation: 91 FR 69977. CBP Docket USCBP-2026-1387.

Effective Date

January 5, 2027


New importer classification and covered entry requirements become effective.

Broker Extension

May 6, 2027


Outside compliance deadline for the specified broker verification obligations where an authorized delayed-compliance request applies.

Affected Businesses

Foreign and U.S. Entities


Foreign IORs, foreign-owned U.S. companies, customs brokers and international sellers should review their import structures.

Important: The new rule does not prohibit every foreign company from importing goods into the United States. Instead, it establishes classifications and different entry procedures. The May 6, 2027 extension is not a blanket postponement for foreign importers.
Introduction

 

A Major Change in U.S. Customs Enforcement

 

For decades, foreign businesses have participated in American commerce by manufacturing products overseas and shipping merchandise directly to customers, distributors, fulfillment centers, and retail warehouses throughout the United States.

Many international companies have established U.S. corporations or limited liability companies to facilitate these activities. Others have operated as nonresident importers, relying on customs brokers, importer identification numbers, customs bonds, and international freight forwarders to arrange customs clearance.

These business structures have supported international trade involving food, dietary supplements, cosmetics, pharmaceutical products, medical devices, electronics, apparel, industrial equipment, and consumer merchandise.

However, the federal government has increasingly focused on customs revenue collection, importer accountability, product safety, supply-chain security, and the accuracy of importer information.

Executive Order 14411, signed on June 3, 2026, directed federal authorities to strengthen customs enforcement and revise importer eligibility requirements.

The November 6, 2026 Interim Final Rule represents a significant implementation of that policy. It adds new regulatory definitions, requires more detailed importer classification, and places additional responsibilities on licensed customs brokers.

For foreign companies, the central question is no longer simply whether they possess a U.S. Employer Identification Number, a customs bond, or a CBP importer identification number.

Businesses must now determine whether their ownership, operations, assets, and legal structure satisfy the new regulatory requirements for classification as a U.S. importer of record.

This guide explains the changes, their practical consequences, and the compliance steps that foreign manufacturers and international sellers should consider before the January 2027 implementation date.


Chapter 1

 

Understanding the Importer of Record

 

An Importer of Record, commonly abbreviated as IOR, is the party identified as responsible for customs entry and associated obligations under applicable U.S. customs laws.

The importer of record has significant responsibilities concerning the accuracy of entry information, tariff classification, customs valuation, country of origin, applicable duties, taxes, fees, and compliance with other import requirements.

Under 19 U.S.C. 1484, the owner or purchaser of merchandise, or a properly designated licensed customs broker, may have the right to make entry, subject to applicable rules.

The importer must exercise reasonable care when providing information to CBP. Errors in customs declarations can lead to additional duties, examinations, administrative actions, penalties, or other enforcement consequences.


Why the IOR Designation Matters

An importer of record is more than a name appearing on a commercial invoice. It is a legally significant designation that determines which party assumes customs responsibilities.

Foreign companies frequently misunderstand the distinction between the importer of record, consignee, customs broker, freight forwarder, and ultimate purchaser.


Importer of Record

The party identified for customs entry and responsible for applicable importer obligations.

Customs Broker

A licensed professional authorized to conduct customs business for clients and, in certain circumstances, act as importer of record.

Consignee

The party designated to receive merchandise. The consignee is not automatically the importer of record.

Freight Forwarder

A logistics provider that coordinates transportation and shipping documentation. This role does not automatically establish IOR responsibility.

 

The new CBP rule makes accurate identification of these parties particularly important. A company should ensure that contracts, commercial invoices, powers of attorney, customs filings, and internal records consistently reflect its actual import structure.


Chapter 2

 

Executive Order 14411 and the November 2026 Rule

 

Executive Order 14411, titled "Strengthening Customs Enforcement," established a federal policy of improving customs accountability and preventing unlawful import practices.

The executive order addresses concerns including undervaluation, inaccurate importer identification, unpaid customs duties, inadequate bonding, and business structures that complicate government enforcement.

It directed CBP and the Department of Homeland Security to review and revise importer eligibility rules and associated enforcement procedures.

The November 2026 Interim Final Rule amends multiple parts of Title 19 of the Code of Federal Regulations.

 

19 CFR Part 110

Introduces definitions and qualification standards for U.S. and foreign importers of record.

19 CFR Part 111

Expands customs broker verification, due diligence, and related recordkeeping responsibilities.

19 CFR Part 141

Establishes procedures for entries by U.S. and foreign importers of record.

19 CFR Parts 142 and 171

Addresses entry-processing consequences and associated enforcement procedures.

 

The rule should be understood as a change in importer eligibility and entry procedures, not simply an update to a registration form.

Foreign businesses should also distinguish the rule's binding regulatory text from the broader policy goals of the executive order. Specific obligations must be evaluated under the applicable regulations and official CBP guidance.

 


Chapter 3

 

Who Qualifies as a U.S. Importer of Record Under the New Rules?

 

New 19 CFR 110.2 establishes the criteria for classification as a U.S. importer of record.

An individual may qualify if the person is a United States citizen or lawful permanent resident.

For a business entity, the requirements are more complex.

An entity must be located in the United States, organized under U.S. law, and satisfy one of two additional alternatives.

Alternative One: U.S. Beneficial Ownership and Control

At all times, at least 51 percent of the entity's beneficial owners, as defined under the rule, must be U.S. citizens or lawful permanent residents and have control of the entity.

This provision requires careful evaluation of beneficial ownership and control. A company cannot necessarily establish compliance merely by appointing a U.S. resident as a manager, director, or authorized representative.

Alternative Two: Significant U.S. Real Property

Alternatively, the entity may qualify if it maintains direct ownership of a significant amount of unencumbered real property in the United States at all times.

The rule does not establish a universal dollar threshold for what constitutes a significant amount of qualifying real property.

Consequently, businesses should not assume that owning any U.S. property, regardless of its value or encumbrances, automatically satisfies this alternative.

 

Important distinction: A U.S.-registered LLC, an EIN, a virtual office, a U.S. bank account, or a customs bond does not independently establish qualification as a U.S. importer of record under 19 CFR 110.2.

 

CBP Verification of U.S. Operations

CBP may consider the company's principal place of business, physical operations, employees, business transactions, capitalization, profitability, and domestic assets when evaluating whether the entity is genuinely located in the United States.

The agency may also examine whether the company functions primarily as an instrumentality of a foreign manufacturer without substantial U.S. business operations.

These factors make advance documentation and an accurate understanding of corporate structure essential.


Chapter 4

 

Foreign-Owned U.S. LLCs: Why Incorporation Alone Is Not Enough

 

Many foreign entrepreneurs establish limited liability companies in states such as Florida, Delaware, Wyoming, Texas, and Nevada.

These entities may possess an EIN, a registered agent, a business bank account, and a U.S. mailing address. They may also maintain customs bonds and import products into Amazon fulfillment centers.

However, the new rule distinguishes legal formation in the United States from qualification as a U.S. IOR.

A company wholly owned by foreign individuals generally cannot rely on the U.S. beneficial ownership alternative unless its ownership and control satisfy the applicable regulatory criteria.

It may nevertheless qualify through the alternative involving significant directly owned unencumbered U.S. real property, provided the remaining requirements are satisfied.

Example: Foreign-Owned Florida LLC

Consider a company incorporated in Florida and wholly owned by a European manufacturer.

The LLC purchases inventory from its parent company and ships products to U.S. distribution centers. It has an EIN, a registered agent, and a commercial bank account.

These facts alone do not demonstrate that the LLC qualifies as a U.S. IOR under the new rule.

The company must evaluate its actual U.S. location, operations, beneficial ownership, control, and any qualifying real property.

If it does not satisfy the U.S. IOR definition, it will be classified as a foreign IOR for purposes of the rule.

That classification does not necessarily terminate the company's ability to import. It changes the procedures and broker arrangements that must be followed.

Avoid Artificial Ownership Arrangements

Businesses should not attempt to create nominal ownership structures, undisclosed nominee relationships, or misleading corporate records to satisfy the rule.

Any restructuring should reflect genuine legal and economic ownership and be reviewed by qualified legal and tax professionals.


Chapter 5

 

Foreign Importers of Record: The CTPAT Requirement

 

Under new 19 CFR 110.3, an importer that does not meet the criteria for a U.S. importer of record is classified as a foreign importer of record.

New 19 CFR 141.21 establishes additional conditions for foreign IORs making covered entries for consumption.

The central operational change involves the Customs Trade Partnership Against Terrorism, commonly known as CTPAT.

Foreign IOR Already Validated Through CTPAT

A foreign importer validated through CTPAT may make covered entries itself when it has the legal right to make entry, or may hire a licensed customs broker.

CTPAT eligibility and validation must be confirmed directly. Not every foreign business is eligible to participate in the program.

Foreign IOR Without CTPAT Validation

A foreign importer that is not CTPAT validated must designate a licensed customs broker that is CTPAT validated to make entry or act as importer of record under the applicable conditions.

This is especially important for foreign manufacturers that currently use customs brokers without CTPAT validation.

A customs broker's license and CTPAT validation are separate qualifications. Businesses should verify both.

 

CTPAT-Validated Foreign IOR

May use the entry procedures permitted by 19 CFR 141.21, subject to its right to make entry and other applicable requirements.

Non-CTPAT Foreign IOR

Must use a licensed, CTPAT-validated customs broker for covered entries, subject to the rule's specific conditions.

 

A foreign business should contact its customs broker well before January 5, 2027 to confirm the broker's CTPAT status, ability to serve foreign IOR clients, and required documentation.

The rule's specified entry restrictions apply to formal consumption entries and covered informal entries filed using CBP Forms 3461 or 7501 or their electronic equivalents. Other entry situations require separate analysis.


Chapter 6

Customs Brokers: Expanded Verification and Due Diligence


The rule places additional responsibilities on licensed customs brokers, particularly when they declare that a client qualifies as a U.S. importer of record.

Under revised 19 CFR 111.29, brokers must verify the client's qualification before making the relevant declaration to CBP.

This involves requesting and reviewing records that support the client's eligibility.

Depending on the circumstances, documentation may include corporate formation records, proof of citizenship or lawful permanent residence, ownership information, financial statements, property records, and other relevant evidence.

Additional Recordkeeping

The rule also addresses retention of broker verification records. Such records must generally be retained for five years from the date verification is conducted.

Importers should anticipate more detailed questions from brokers regarding ownership, management, physical operations, assets, and the nature of the business.

Companies that cannot provide adequate records may encounter difficulties when brokers attempt to confirm the appropriate IOR classification.

 

Practical recommendation: Prepare a complete corporate verification file before the first shipment subject to the new requirements. Do not wait until cargo arrives at a U.S. port.

Chapter 7

 

CBP Form 5106 and Importer Identification

 

CBP Form 5106 is used to create or update importer identity information in CBP systems.

Foreign businesses frequently use the form when establishing importer identification records or updating existing information.

However, possession of an importer number does not independently establish qualification as a U.S. importer of record.

Under the new rules, the classification of the importer must be evaluated separately from the existence of its CBP identification record.

Accuracy of Importer Information

CBP has increased its attention to importer identity information, including the accuracy of business names, addresses, ownership details, and identifying records.

Companies should review existing Form 5106 information and ensure that changes in their legal structure or business identity are properly reflected.

Incorrect or inconsistent information can complicate entry processing and may result in additional verification or enforcement actions.

New Entry Declarations

CBP has also announced updates to Forms 3461 and 7501 and their electronic equivalents to implement the new IOR classification requirements.

Importers should coordinate with their customs brokers to ensure that the correct classification is declared for each applicable entry.


Chapter 8

 

Customs Bonds, Domestic Assets and Financial Accountability

 

Customs bonds provide financial security for certain obligations owed to CBP, including duties, taxes, fees, and other covered liabilities.

A foreign importer may be required to maintain an appropriate customs bond depending on the entry type and applicable regulatory requirements.

Executive Order 14411 directed federal authorities to strengthen financial accountability through bonding, domestic assets, and related requirements.

Nevertheless, businesses should distinguish these policy objectives from the specific provisions implemented by the November 2026 rule.

The rule does not establish a single universal dollar amount of U.S. assets that automatically qualifies every foreign-owned company as a U.S. IOR.

Likewise, maintaining a customs bond does not replace the classification requirements under 19 CFR 110.2.

Financial Documentation

Foreign-owned entities should be prepared to document capitalization, U.S. business operations, assets, and other relevant financial circumstances.

When real property is relied upon for the alternative U.S. IOR qualification, ownership records and evidence of unencumbered value may be particularly important.

A company should obtain professional guidance before purchasing property, changing its capitalization, or restructuring ownership solely to address customs eligibility.


Chapter 9

 

Amazon FBA and International E-Commerce Sellers

 

Amazon Fulfillment by Amazon (FBA) allows international businesses to store products in U.S. fulfillment centers and distribute them to American consumers.

Many foreign sellers manufacture products abroad and arrange delivery directly to Amazon warehouses.

The new CBP rule creates important considerations for these businesses, particularly when the seller or its U.S. subsidiary is designated as importer of record.

Amazon Is Not Automatically the IOR

The fact that merchandise is shipped to an Amazon fulfillment center does not make Amazon the importer of record.

The importer designation must be established through an appropriate customs arrangement, consistent with applicable law and platform requirements.

Foreign-Owned Amazon Seller LLCs

An international seller may operate through a U.S. LLC that is entirely owned by foreign individuals.

That entity should not assume U.S. IOR status based solely on its incorporation or EIN.

If it is classified as a foreign IOR, the seller must evaluate the requirements of 19 CFR 141.21 and its customs broker arrangements.

 

Preparing Amazon Shipments

 

Before Export

Confirm the legal importer, review the broker's CTPAT status, verify the customs bond, and prepare accurate commercial documents.

Before U.S. Delivery

Confirm applicable FDA requirements, product admissibility, customs entry documentation, and Amazon warehouse delivery instructions.

 

Importers should also review Incoterms and contracts with suppliers, freight forwarders, and logistics providers.

Terms such as Delivered Duty Paid (DDP) allocate commercial responsibilities but do not automatically determine who legally qualifies as importer of record.

An appropriate import structure must satisfy both customs law and the relevant contractual obligations.


Chapter 10

 

FDA-Regulated Products: Customs Compliance Is Only One Requirement

 

Foreign companies importing food, dietary supplements, cosmetics, pharmaceuticals, and medical devices must consider both CBP and U.S. Food and Drug Administration requirements.

CBP administers customs entry procedures and enforces numerous trade requirements, while FDA regulates the admissibility and compliance of products within its jurisdiction.

The new CBP rule does not replace FDA establishment registration, product listing, labeling, or other applicable obligations.

 

Food and Beverages

Foreign food facilities may require FDA registration under 21 CFR Part 1. Food imports may also require Prior Notice, FSVP compliance, and other applicable controls.

Dietary Supplements

Importers must evaluate facility registration, dietary supplement labeling, ingredient compliance, manufacturing controls, and applicable FSVP requirements.

Cosmetics

MoCRA may require facility registration, product listing, safety substantiation, adverse event reporting, and compliant labeling, subject to applicable exemptions.

Pharmaceutical Products

Drug imports may involve establishment registration, drug listing, applicable marketing authorization, labeling, and other FDA requirements.

Medical Devices

Requirements may include establishment registration, device listing, applicable premarket authorization, quality-system compliance, and Initial Importer obligations.

Animal and Pet Products

Animal food, pet treats, veterinary drugs, and other animal products may be subject to FDA requirements that differ according to product classification.

 

A foreign manufacturer may therefore satisfy the CBP importer classification requirements while still encountering FDA detention or refusal because its products do not meet applicable FDA requirements.

Conversely, FDA registration does not establish eligibility to act as a U.S. IOR under the new customs rule.


Chapter 11

 

Understanding the Different Regulatory Roles

 

Foreign companies often confuse the terms U.S. Agent, FSVP Importer, FSVP Agent, Initial Importer, and Importer of Record.

These roles arise under different legal frameworks and should not be treated as interchangeable.

 

CBP Importer of Record

Responsible for customs entry obligations under applicable CBP laws and regulations.

FDA U.S. Agent

Serves as the designated U.S. contact for certain foreign establishments under applicable FDA registration requirements.

FSVP Importer

The U.S. owner or consignee of food at the time of entry, or the designated U.S. agent or representative of the foreign owner or consignee when no U.S. owner or consignee exists.

Medical Device Initial Importer

An entity that furthers marketing of a device from a foreign manufacturer to the party making final delivery or sale to the ultimate consumer, without repackaging or otherwise changing the device's packaging.

 

A single organization may perform more than one role when legally eligible and properly designated.

However, appointing an FDA U.S. Agent does not automatically create a CBP importer of record.

Likewise, appointing an FSVP representative does not automatically authorize that party to clear merchandise through customs.

Companies should document each regulatory role separately, identify the responsible entity, and maintain appropriate agreements.


Chapter 12

 

Consequences of Noncompliance

 

Failure to comply with the new requirements can create operational and financial difficulties for importers and customs brokers.

The specific consequences depend on the violation, the entry circumstances, and the applicable enforcement authority.

Incorrect U.S. IOR Declarations

If CBP determines that a party incorrectly declared qualification as a U.S. importer of record, additional entry-processing requirements may apply.

The amendments to 19 CFR Part 142 address circumstances involving entry summary filing and discontinuance of immediate delivery privileges.

Customs Delays and Additional Costs

A business using an ineligible import structure may need to revise its customs arrangements before covered merchandise can be entered properly.

This can produce storage charges, demurrage, additional broker fees, missed delivery appointments, and supply-chain disruptions.

False or Inaccurate Information

Materially inaccurate customs declarations may also raise issues under other applicable customs enforcement provisions.

Companies should avoid misrepresenting beneficial ownership, physical presence, property ownership, or importer identity.

FDA Detention and Refusal

For FDA-regulated products, separate FDA violations may result in examination, detention, refusal of admission, or other enforcement actions.

Customs compliance and FDA compliance must therefore be addressed together.


Chapter 13

 

2027 Compliance Timeline and Preparation Plan


Foreign importers should begin preparing before the January 2027 effective date rather than waiting for the first shipment of the new year.


November 6, 2026

Rule Published


Review the Interim Final Rule and identify the entities currently acting as importers of record.

November–December 2026

Internal Compliance Review


Evaluate beneficial ownership, U.S. operations, real property, customs broker status, and import documentation.

January 5, 2027

Rule Effective


New classifications and covered entry requirements take effect. The public comment period also closes.

May 6, 2027

Broker Compliance Deadline


Outside deadline for applicable delayed broker verification compliance. This does not suspend all importer obligations.


Recommended Compliance Checklist


  1. Identify the legal importer. Determine which company or individual is currently designated as importer of record for U.S. shipments.
  2. Review corporate ownership. Identify beneficial owners, ownership percentages, control arrangements, and relevant citizenship or residency information.
  3. Assess U.S. operations. Document the company's actual domestic location, business activities, employees, assets, and capitalization.
  4. Evaluate IOR classification. Determine whether the business meets 19 CFR 110.2 or must operate as a foreign IOR.
  5. Verify the customs broker. Confirm the broker's license and CTPAT validation status where applicable.
  6. Review importer records. Check CBP Form 5106 information, powers of attorney, bond arrangements, and relevant entry records.
  7. Review FDA obligations. Confirm establishment registrations, product listings, FSVP responsibilities, labeling, and other applicable requirements.
  8. Update commercial contracts. Review purchase agreements, Incoterms, logistics contracts, and responsibility for customs clearance.
  9. Prepare a compliance file. Maintain organized records that can support broker verification and government inquiries.
  10. Monitor official guidance. Review CBP announcements, Federal Register updates, and subsequent regulatory developments.

Chapter 14

 

How Bilingual FDA Consultants Can Assist Foreign Companies

 

International regulatory compliance can be challenging for companies operating outside the United States.

Foreign manufacturers must often coordinate multiple regulatory requirements while managing production, international transportation, customs documentation, product registration, marketing, and sales.

Language barriers can make these responsibilities even more difficult, particularly when companies must communicate with U.S. authorities, customs brokers, suppliers, and American business partners.

Bilingual FDA Consultants help international businesses understand their obligations and organize the documentation needed for regulatory compliance.

ITB HOLDINGS LLC offers regulatory consulting services to assist foreign companies exporting FDA-regulated products to the United States.

 

Regulatory Consulting Services

 

Importer of Record Compliance Review

Review proposed importer structures, organize supporting documentation, and coordinate regulatory questions with licensed customs brokers and qualified legal advisers.

CBP Form 5106 Assistance

Assist with preparing importer identification information and coordinating appropriate submissions through authorized channels.

FDA Food Facility Registration

Assist foreign food manufacturers with FDA registration, required updates, renewals, and U.S. Agent arrangements.

FSVP Compliance Support

Assist with FSVP responsibility assessments, supplier verification documentation, and food importer compliance.

Medical Device Compliance

Support establishment registration, device listing, Initial Importer requirements, and other applicable FDA procedures.

Cosmetics and MoCRA

Assist with applicable cosmetic facility registration, product listing, labeling, and regulatory documentation.

Drug Registration and Listing

Support applicable pharmaceutical establishment registration, drug listing, labeling reviews, and regulatory coordination.

FDA Import Detention Assistance

Help companies organize records, evaluate regulatory concerns, and prepare appropriate responses to FDA import issues.

 

Multilingual Communication

Bilingual regulatory assistance can help manufacturers and exporters communicate more effectively about U.S. compliance requirements.

International clients may require assistance in English, French, Spanish, Italian, German, Dutch, Portuguese, Chinese, Japanese, or Korean, depending on the service and consultant availability.

Clear communication helps reduce misunderstandings concerning importer responsibilities, documentation, deadlines, and regulatory procedures.

A Coordinated Compliance Approach

Import compliance often requires several professionals working together.

FDA consultants can assist with FDA-specific requirements and regulatory coordination. Licensed customs brokers handle customs business within their authorized scope, while attorneys may advise on corporate ownership, legal eligibility, and restructuring.

This coordinated approach allows foreign businesses to address customs and FDA obligations without confusing the responsibilities of different service providers.

For companies operating internationally, outsourcing appropriate regulatory documentation and compliance support can free management to concentrate on manufacturing, product development, advertising, distribution, and customer relationships.


Conclusion

 

Preparing for a New Era of U.S. Importer Accountability

 

The November 6, 2026 CBP Interim Final Rule represents a major development in U.S. customs compliance.

By introducing new definitions for U.S. and foreign importers of record, the rule changes how businesses must evaluate their eligibility to make covered customs entries.

Foreign-owned U.S. companies can no longer assume that incorporation, an EIN, a registered agent, or a customs bond automatically establishes U.S. IOR qualification.

Businesses that do not satisfy the U.S. IOR criteria must consider the entry procedures applicable to foreign IORs, including CTPAT-related broker requirements.

Customs brokers must also prepare for additional verification and recordkeeping responsibilities.

For foreign manufacturers and Amazon FBA sellers, the practical implications include reviewing corporate structures, confirming broker arrangements, updating importer records, and coordinating logistics well before cargo reaches American ports.

Companies importing FDA-regulated products face an additional layer of responsibility. Customs entry compliance must be coordinated with applicable FDA registration, listing, labeling, FSVP, and product admissibility requirements.

The January 5, 2027 effective date makes advance planning particularly important. The May 6, 2027 broker delayed-compliance deadline should not be interpreted as a general extension for all importers.

With proper preparation, reliable documentation, qualified customs professionals, and appropriate FDA regulatory support, foreign businesses can develop more resilient import procedures and reduce avoidable compliance risks.


ITB HOLDINGS LLC - Bilingual FDA Consultants assisting international companies with U.S. FDA and import compliance
Professional U.S. Regulatory Assistance

 

Need Help Preparing for the New 2027 CBP Importer of Record Rules?

 

Let experienced bilingual regulatory consultants help your company understand its U.S. compliance responsibilities.

Are you a foreign manufacturer, international exporter, Amazon FBA seller, or foreign-owned U.S. company shipping products to the United States?

The new CBP requirements may affect your importer classification, customs broker arrangements, documentation, and shipping procedures.

ITB HOLDINGS LLC provides professional FDA regulatory consulting and import compliance coordination services for companies doing business in the United States.

 

Importer Compliance Assessment

Review importer identity, corporate documentation, regulatory responsibilities, and questions requiring customs broker or legal evaluation.

FDA Compliance Assistance

Obtain support with FDA registration, U.S. Agent services, FSVP, medical devices, cosmetics, drugs, and related documentation.

 

Managing an international business can be demanding. Regulatory paperwork should not distract your company from manufacturing quality products, developing new markets, and serving customers.

Our consulting services can help organize applicable FDA requirements and coordinate compliance documentation so your business can focus on growth.

 

 

Prepare early. Verify your importer classification. Protect your U.S. supply chain.


Official Regulatory References

Further Reading

  1. CBP Interim Final Rule: Heightened Requirements for Foreign Importers of Record.
    91 FR 69977, November 6, 2026.
    Read the Federal Register Rule
  2. Executive Order 14411: Strengthening Customs Enforcement.
    June 3, 2026.
    Read the Executive Order
  3. U.S. Customs and Border Protection.
    Official trade compliance resources.
    CBP Trade Resources
  4. CBP Cargo Systems Messaging Service.
    CSMS #70381183, November 6, 2026.
    Entry Form Updates
  5. U.S. Food and Drug Administration.
    Importing FDA-regulated products.
    FDA Import Program
  6. Regulations.gov.
    CBP Docket USCBP-2026-1387.
    Federal Rulemaking Portal

Regulatory Disclaimer: This article provides general educational information based on the November 6, 2026 Interim Final Rule and related federal guidance. It is not legal advice or a determination of any particular company's importer eligibility. Regulatory requirements may be amended or clarified through subsequent agency action.

Importer classification, customs entry eligibility, and corporate restructuring questions should be reviewed with appropriately qualified professionals. Customs business must be performed by persons authorized under applicable law.